BackAnnexin Pharmaceuticals AB Overview

Annexin Pharmaceuticals AB Goodwill

Latest goodwill for ANNX.ST: $0.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$0.00

Peer trimmed avg / median

Loading

Annexin Pharmaceuticals AB Goodwill History

Loading

Annexin Pharmaceuticals AB vs. peers: Goodwill Comparison

Loading

Annexin Pharmaceuticals AB Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Annexin Pharmaceuticals AB (ANNX.ST) FAQ

Annexin Pharmaceuticals AB's goodwill stands at $0 as of June 2026. In the prior-year period, the figure was $0. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Annexin Pharmaceuticals AB reported $0 in goodwill versus $0 a year earlier. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

In the prior-year period, the figure was $0. Sustained growth in goodwill can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.

The history chart shows how Annexin Pharmaceuticals AB's goodwill evolved across reporting periods, while the comparison chart places ANNX.ST next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.

Yes — within Healthcare, goodwill is commonly used to spot outliers. Annexin Pharmaceuticals AB's reading of $0 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.